2Xu Hb,Elizabeth B,Oliveira-Sales F,et al.Upregulation of junctional adhesion molecule.A is a putative prognostic marker of hypertension[J] .Cardiovasc Res,2012,96(3): 112-114.
4Guilbert JJ. The world health report 2002: reducing risks, promoting healthy life [J]. Educ Health (Abingdom), 2003, 16 (2) : 230.
5Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report [J]. JAMA, 2003, 2.89 (19) : 2 560-572.
6Ezzati M, Lopez AD, Rodgers A, et al. Selected major risk factors and global and regional burden of disease [J]. Lancet, 2002,360 (9343) : 1 347 -360.
7D'Agostion RB, Belanger AJ, Kannel WB, et al. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study [ J ]. BMJ, 1991, 303 ( 6799 ) : 385- 389.
8Tylicki L, Renke M, Rutkowski P, et al. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection : an open, controlled, randomized study [ J ]. Scand J Urol Nephrol, 2008, 42 (4) : 381-388.
9Zanchetti A, Hansson L, Clement D, et al. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: dose a J-shaped curve exist in smokers [ J ]. J Hypertens, 2003, 21 (4) : 797-804.
10Cuspidi C, Meani S, Valerlo C, et al. Effects of angiotensin Ⅱ receptor blockade-based therapy with losartan on left ventricular hypertrophy and geometry in previously treated hypertensive patients [ J ]. Blood Press, 2006, 15 (2) : 107-115.
